title: Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.
authors.forename: Juan Angel
authors.initials: JA
authors.lastname: Jover
authors.forename: Cesar
authors.initials: C
authors.lastname: Hernández-Garcia
authors.forename: Inmaculada C
authors.initials: IC
authors.lastname: Morado
authors.forename: Emilio
authors.initials: E
authors.lastname: Vargas
authors.forename: Antonio
authors.initials: A
authors.lastname: Bañares
authors.forename: Benjamin
authors.initials: B
authors.lastname: Fernandez-Gutierrez
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D013700:Giant Cell Arteritis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D010919:Placebos; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D015203:Reproducibility of Results; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D010919:Placebos; D011241:Prednisone; D008727:Methotrexate